Kenneth C. Frazier - Aug 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Executive Chair, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Kenneth C. Frazier
Stock symbol
MRK
Transactions as of
Aug 3, 2022
Transactions value $
$0
Form type
4
Date filed
8/19/2022, 03:19 PM
Previous filing
May 26, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 706K Aug 3, 2022 Direct F1
holding MRK Common Stock - 401(k) Plan 4.44K Aug 3, 2022 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +28.5K $0.00 28.5K Aug 3, 2022 Common Stock 28.5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through July 8, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4 These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 8/3/2023.